Fujifilm says COVID-19 drug research may drag on into July
FILE PHOTO: Tablets of Avigan (generic name : Favipiravir), a drug approved as an anti-influenza drug in Japan and developed…
AstraZeneca scores twin drug approvals alongside vaccine progress
(Reuters) – Britain’s AstraZeneca has clinched expanded regulatory backing for two medications, including one for blockbuster cancer treatment Lynparza, in…
Michigan, California move to reopen factories as U.S. jobless ranks grow
DETROIT/SACRAMENTO, Calif. (Reuters) – Michigan and California, two U.S. manufacturing powerhouses, acted on Thursday to allow factories to reopen from…
Roche gets FDA emergency use approval for COVID-19 antibody test
FILE PHOTO: The logo of Swiss drugmaker Roche is seen at its headquarters in Basel, Switzerland January 30, 2020. REUTERS/Arnd…
U.S. FDA approves first rapid coronavirus test with 45 minutes detection time
FILE PHOTO: A computer image created by Nexu Science Communication together with Trinity College in Dublin, shows a model structurally…
Germany tries to stop U.S. poaching German firm seeking coronavirus vaccine
BERLIN (Reuters) – Berlin is trying to stop Washington from persuading a German company seeking a coronavirus vaccine to move…
Germany tries to stop U.S. from luring away firm seeking coronavirus vaccine
BERLIN (Reuters) – Berlin is trying to stop Washington from persuading a German company seeking a coronavirus vaccine to move…
Pharma firms not making enough progress against superbugs: report
LONDON (Reuters) – Drug companies are not making progress against the spread of antibiotic resistance at a scale and speed…
Biogen scraps development of therapy for rare brain disease
(Reuters) – Biogen Inc said on Friday it would discontinue the development of its experimental therapy for a rare brain…
Sarepta shares surge after surprise approval of Duchenne Muscular Dystrophy drug
(Reuters) – Shares of Sarepta Therapeutics Inc (SRPT.O) soared 36% on Friday after U.S. regulators shocked Wall Street by approving…
U.S. FDA gives early approval to Sarepta’s newest DMD treatment
FILE PHOTO: The headquarters of the U.S. Food and Drug Administration (FDA) is seen in Silver Spring, Maryland November 4,…
Half of lymphoma patients alive three years after Gilead cell therapy treatment: study
(Reuters) – Nearly half of lymphoma patients treated with Gilead Sciences Inc’s Yescarta were alive at least three years after…
Teva partners with Israeli institutes for early-stage drug research
FILE PHOTO: The logo of Teva Pharmaceutical Industries is seen during a news conference by its CEO, Kare Schultz, to…
FDA approves Global Blood Therapeutics sickle cell disease drug
(Reuters) – The U.S. Food and Drug Administration said on Monday it approved a drug from Global Blood Therapeutics Inc…
FDA approves Aquestive’s ALS treatment
(Reuters) – The U.S. Food and Drug Administration on Friday approved bit.ly/2pIFzi5 Aquestive Therapeutics’ treatment for neurological disorder amyotrophic lateral…
Roche drug for spinal muscular atrophy hits target in late-stage trial
ZURICH (Reuters) – Roche’s bid to rival Biogen and Novartis in treating spinal muscular atrophy (SMA) got a lift on…
AstraZeneca succeeds in treating lupus in late-stage study
The company logo for pharmaceutical company AstraZeneca is displayed on a screen on the floor at the New York Stock…
FDA approves Alexion’s Ultomiris for another rare blood disease
(Reuters) – The U.S. Food and Drug Administration on Friday approved Alexion Pharmaceuticals Inc’s treatment for a second rare blood…
Vectura, Sandoz win ruling on inhaler packaging case against GSK
(Reuters) – Vectura Group said on Friday a British court had ruled in its favor on the packaging of a…
E-sniffer predicts non-responders to lung cancer immunotherapy
An electronic “nose” that detects chemicals in the breath of lung cancer patients may help distinguish between those who will…
Democrats’ drug pricing proposal ‘dead on arrival’ in Senate: leading Republican
FILE PHOTO: Sen. John Thune (R-SD) speaks to Capitol Hill reporters following the Republicans’ weekly policy luncheon in Washington, U.S.,…
FDA approves Boehringer’s lung disease drug
(Reuters) – The U.S. Food and Drug Administration on Friday approved German drugmaker Boehringer Ingelheim’s Ofev capsules for a rare…
Congolese girl, 9, dies of Ebola in Uganda- hospital official
KAMPALA (Reuters) – A nine-year-old girl has died of Ebola in the East African nation of Uganda, a hospital official…
Ebola death toll in east Congo outbreak climbs above 2,000
GOMA, Democratic Republic of Congo (Reuters) – The death toll from Democratic Republic of Congo’s year-long Ebola outbreak has climbed…
Retrophin scraps nervous system disorder study, shares dive
(Reuters) – Retrophin Inc said on Thursday it was discontinuing the late-stage study for its rare neurological disorder treatment after…
WHO says eradicating malaria ‘can be done’, but first aim is to control it
LONDON, Aug 23 – Eradicating malaria is biologically feasible and a lofty aim, the World Health Organization said on Friday,…
GSK builds oncology pipeline as drug shown to help myeloma patients
(Reuters) – GlaxoSmithKline said an experimental multiple myeloma treatment has shown a meaningful response in patients that have run out…
Ebola appears contained in Goma, but flares in other parts of Congo: WHO
GENEVA (Reuters) – Ebola appears to be under control in the city of Goma in Congo but it has flared…
Congo has given over 200,000 people Merck Ebola vaccine: government
GOMA, Congo (Reuters) – Congolese authorities and health workers vaccinated more than 200,000 people against Ebola in August, the government…
Roche’s personalized cancer treatment wins FDA approval
FILE PHOTO: The logo of Swiss pharmaceutical company Roche is seen outside the Shanghai Roche Pharmaceutical Co. Ltd. headquarters in…
AbbVie prices new rheumatoid arthritis drug at $59,000 a year
(Reuters) – AbbVie Inc has priced its new rheumatoid arthritis treatment at $59,000 a year after gaining U.S. approval on…
FDA approves Celgene’s bone marrow cancer treatment
(Reuters) – The U.S. Food and Drug Administration on Friday approved Celgene Corp’s Inrebic to treat certain rare forms of…
AbbVie prices new rheumatoid arthritis drug at $59,000/yr
(Reuters) – AbbVie Inc has priced its new rheumatoid arthritis treatment at $59,000 a year after gaining U.S. approval on…
Regeneron’s Ebola treatment proves superior to rival in trial
(Reuters) – Regeneron Pharmaceuticals Inc said on Monday its experimental treatment for Ebola proved superior to a rival therapy from…
Scientists hail promise of first effective Ebola treatments in Congo trial
LONDON (Reuters) – Scientists are a step closer to finding the first effective treatments for the deadly Ebola haemorrhagic fever…
Sarepta says adverse event report for DMD gene therapy erroneously submitted
(Reuters) – Sarepta Therapeutics Inc said on Thursday it was informed that an adverse event report was erroneously submitted to…
Roche’s Tecentriq recommended for EU approval to treat lung cancer form
FILE PHOTO: The logo of Swiss drugmaker Roche is seen at its headquarters in Basel, Switzerland February 1, 2018. REUTERS/Arnd…
European panel okays GW Pharma cannabis drug for epilepsy
(Reuters) – GW Pharmaceuticals’ marijuana-based treatment Epidyolex has won a positive recommendation for marketing approval from a European Medicines Agency…
Many deadly common cancers get little charity funding
(Reuters Health) – Many of the most common and lethal cancers get the fewest research dollars from fundraising advocacy groups,…
Multidrug-resistant malaria spreading in Southeast Asia: study
FILE PHOTO: Anopheles minimus mosquitoes are pictured at a lab in the Public Health Ministry in Bangkok, Thailand, November 9,…
Gilead invests $5 billion to deepen ties with biotech Galapagos
(Reuters) – U.S. antiviral drugmaker Gilead Sciences (GILD.O) will invest $5.1 billion in a major expansion of its partnership with…
Trump administration drug officials clash over how to combat fentanyl copycats
WASHINGTON (Reuters) – Trump administration officials are divided over part of a proposal to crack down on illicit versions of…
Conatus Pharma to explore options as liver disease drug fails trial
(Reuters) – Conatus Pharmaceuticals Inc said on Monday it plans to explore options and implement a restructuring plan after its…
Mesh implants work for bladder leakage, long-term safety unclear
(Reuters Health) – Several different types of mesh implant surgery may be effective for treating bladder leaks, but the long-term…
Experimental mobile app helps manage migraines
(Reuters Health) – A smartphone-based relaxation app could help migraine sufferers reduce the number of headaches they get each month,…
Bluebird prices gene therapy at 1.58 million euros over 5 years
(Reuters) – Bluebird bio Inc on Friday set a price for its gene therapy, Zynteglo, at 1.58 million euros ($1.78…
‘Smart’ hearing aids would identify speakers in crowded room
(Reuters Health) – People wearing hearing aids often struggle to differentiate between speakers in a crowded environment, but a small…
Many U.S. allergists now prescribe tablets instead of shots
(Reuters Health) – Almost three in four U.S. allergy specialists are prescribing tablets to ease symptoms caused by pollen, ragweed…
FDA approves expanded label for Regeneron/Sanofi’s cholesterol drug
(Reuters) – The U.S. Food and Drug Administration on Friday approved Regeneron Pharmaceuticals Inc’s cholesterol drug Praluent as a treatment…
Trump says he is holding big Pharma accountable in opioid fight
ATLANTA (Reuters) – U.S. President Donald Trump touted progress in the fight against opioid abuse on Wednesday and promised to…
Merck’s Keytruda wins FDA approval as combination therapy for kidney cancer
FILE PHOTO: The Merck logo is seen at a gate to the Merck & Co campus in Linden, New Jersey,…
Lower dose of Pfizer-Lilly painkiller misses main goals in late stage study
(Reuters) – A lower dose of non-opioid painkiller developed by Pfizer Inc and Eli Lilly and Co failed to meet…
Lower dose of Pfizer-Lilly painkiller misses main goals in late stage study
(Reuters) – A lower dose of non-opioid painkiller developed by Pfizer Inc and Eli Lilly and Co failed to meet…
Zogenix’s seizure drug filing fails to pass U.S. FDA scrutiny
(Reuters) – The U.S. Food and Drug Administration on Monday refused to fully review the marketing application for Zogenix Inc’s…
New Jersey jury finds J&J not liable in latest talc cancer trial
(Reuters) – A New Jersey jury on Wednesday cleared Johnson & Johnson of liability in a lawsuit brought by a…
J&J settles three mesothelioma talc cases-plaintiffs’ lawyer
A bottle of Johnson and Johnson Baby Powder is seen in a photo illustration taken in New York, February 24,…
New Jersey jury finds J&J not liable in latest talc cancer trial
(Reuters) – A New Jersey jury on Wednesday cleared Johnson & Johnson of liability in a lawsuit brought by a…
Google glass helps kids with autism read facial expressions
(Reuters Health) – Children with autism may have an easier time reading facial expressions and navigating social interactions when they…
Jazz Pharma’s sleep disorder treatment gets FDA nod
(Reuters) – The U.S. Food and Drug Administration approved Jazz Pharmaceuticals Plc’s treatment for patients with a form of sleep…
Amarin’s Vascepa cuts occurrence of serious heart problems 30 percent: study
(Reuters) – A high dose of Amarin Corp’s Omega-3 drug Vascepa significantly reduced the occurrence of first and subsequent heart…